APG-1252 combined with Cabozantinib inhibits hepatocellular carcinoma by suppressing MEK/ERK and CREB/Bcl-xl pathways.
Di T, Luo QY, Song JT, Yan XL, Zhang L, Pan WT, Guo Y, Lu FT, Sun YT, Xia ZF, Yang LQ, Qiu MZ, Yang DJ, Sun J.
Di T, et al. Among authors: yang dj, yang lq.
Int Immunopharmacol. 2024 Sep 30;139:112615. doi: 10.1016/j.intimp.2024.112615. Epub 2024 Jul 20.
Int Immunopharmacol. 2024.
PMID: 39032475